Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
SUSPENDED
NCT03616236
PHASE3

Buprenorphine for Probationers and Parolees: Bridging the Gap Into Treatment

Sponsor: Friends Research Institute, Inc.

View on ClinicalTrials.gov

Summary

This five-year study will evaluate the effectiveness of the administration of buprenorphine bridge treatment (BBT) to probationers and parolees compared to treatment as usual (TAU), which consists of referral to a community buprenorphine treatment program.

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

320

Start Date

2022-07-01

Completion Date

2026-12-30

Last Updated

2026-11-12

Healthy Volunteers

Yes

Conditions

Interventions

DRUG

Buprenorphine/Naloxone

Participants will begin buprenorphine pharmacotherapy using the MedicaSafe buprenorphine dispensing device immediately after an on-site intake at a community supervision office and continue such treatment until they are transitioned to community buprenorphine treatment

OTHER

Treatment as usual

Participants will receive a referral to buprenorphine treatment in the community

Locations (1)

Division of Parole & Probation

Baltimore, Maryland, United States